[go: up one dir, main page]

AR076041A1 - Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral - Google Patents

Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Info

Publication number
AR076041A1
AR076041A1 ARP100101093A ARP100101093A AR076041A1 AR 076041 A1 AR076041 A1 AR 076041A1 AR P100101093 A ARP100101093 A AR P100101093A AR P100101093 A ARP100101093 A AR P100101093A AR 076041 A1 AR076041 A1 AR 076041A1
Authority
AR
Argentina
Prior art keywords
biomarkers
expression
under
regulates
extent
Prior art date
Application number
ARP100101093A
Other languages
English (en)
Inventor
Ying Yang
Harsh M Trivedi
Tao Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR076041A1 publication Critical patent/AR076041A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicacion 1: Un método para identificar un compuesto util para el tratamiento de una enfermedad o condicion de la cavidad oral, caracterizado porque incluye: obtener una primera muestra gingival de un mamífero que sufra de una enfermedad o condicion de la cavidad oral; obtener una segunda muestra gingival de la cavidad oral del mencionado mamífero; poner en contacto la mencionada primera muestra con un compuesto de prueba; poner en contacto la mencionada segunda muestra con un control positivo, en donde el mencionado control positivo es un compuesto que se sabe que bajo-regula la expresion de uno o más biomarcadores; medir la extension hasta la que el mencionado compuesto de prueba bajo-regula la expresion de uno o más de los mencionados biomarcadores; medir la extension hasta la que el mencionado control positivo bajo-regula la expresion de uno o más de los mencionados biomarcadores; y comparar la extension hasta la que el mencionado compuesto de prueba bajo-regula la expresion de uno o más de los mencionados biomarcadores, con la extension hasta la que el mencionado control positivo bajo-regula la expresion de uno o más de los mencionados biomarcadores; en donde un compuesto de prueba que bajo-regula la expresion de uno o más de los mencionados biomarcadores en una extension igual o mayor que el mencionado control positivo, es un compuesto util para tratar una enfermedad o condicion de la cavidad oral.
ARP100101093A 2009-04-01 2010-03-31 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral AR076041A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01

Publications (1)

Publication Number Publication Date
AR076041A1 true AR076041A1 (es) 2011-05-11

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101093A AR076041A1 (es) 2009-04-01 2010-03-31 Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral

Country Status (15)

Country Link
US (1) US8753820B2 (es)
EP (1) EP2414837B1 (es)
JP (1) JP5643288B2 (es)
CN (1) CN102549432B (es)
AR (1) AR076041A1 (es)
BR (1) BRPI1013184A2 (es)
CA (1) CA2753718C (es)
CO (1) CO6430490A2 (es)
MX (1) MX2011008439A (es)
MY (1) MY179250A (es)
RU (1) RU2523383C2 (es)
SG (1) SG173461A1 (es)
TW (1) TWI481870B (es)
WO (1) WO2010115034A2 (es)
ZA (1) ZA201106056B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
JP7245174B2 (ja) * 2017-05-24 2023-03-23 コーニンクレッカ フィリップス エヌ ヴェ 唾液のｈｇｆ及びｍｍｐ－８に基づく歯周炎の診断
US20200116738A1 (en) * 2017-05-24 2020-04-16 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
EP3631457A1 (en) 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis based on salivary il-1beta and mmp-9
EP3701269A1 (en) 2017-10-27 2020-09-02 The Regents of The University of California Salivary extracellular rna biomarkers for gingivitis
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
US5840302A (en) 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
US6482418B1 (en) 1996-06-12 2002-11-19 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical preparations comprising dialkenyl carbonates
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
JP2003518627A (ja) 1999-12-03 2003-06-10 バクスター・インターナショナル・インコーポレイテッド 自動イムノアッセイシステムを用いる使用のための発熱性試験
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
CA2514061A1 (en) 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
US7202234B2 (en) 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
AU2004297914A1 (en) 2003-12-03 2005-06-23 Whitehead Institute For Biomedical Research Use of T-cadherin as a target
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Ｎｆａｔ２発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP2009523029A (ja) * 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
WO2009048841A1 (en) 2007-10-09 2009-04-16 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
SG173461A1 (en) 2011-09-29
RU2011144032A (ru) 2013-05-10
TW201102653A (en) 2011-01-16
TWI481870B (zh) 2015-04-21
JP2012522994A (ja) 2012-09-27
BRPI1013184A2 (pt) 2016-04-12
RU2523383C2 (ru) 2014-07-20
WO2010115034A2 (en) 2010-10-07
US8753820B2 (en) 2014-06-17
CN102549432A (zh) 2012-07-04
MY179250A (en) 2020-11-02
CA2753718C (en) 2015-06-23
US20120028261A1 (en) 2012-02-02
MX2011008439A (es) 2011-09-06
CA2753718A1 (en) 2010-10-07
CN102549432B (zh) 2015-03-25
AU2010232593A1 (en) 2011-08-25
JP5643288B2 (ja) 2014-12-17
EP2414837A2 (en) 2012-02-08
EP2414837B1 (en) 2015-06-03
ZA201106056B (en) 2015-05-27
CO6430490A2 (es) 2012-04-30
WO2010115034A3 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
AR076041A1 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
MX362514B (es) Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
DOP2012000155A (es) Terapia combinada para el tratamiento del cancer y ensayos de diagnostico relacionados
ES2572372T3 (es) Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
BR112014004336A2 (pt) sistema e método para estimar a quantidade de interesse de um sistema de artéria / tecido / veia dinâmico
MX2013002390A (es) Tratamiento de infarto de miocardio usando antagonistas de tgf-beta.
CY1119867T1 (el) Αναστολεις vap-1 για χρηση στη θεραπεια ινωτικων καταστασεων
EP4447854A4 (en) DIAGNOSIS OF DENTAL CAVITIES USING ARTIFICIAL INTELLIGENCE
BR112021015222A2 (pt) Métodos, sistemas e kits para tratamento de doença inflamatória de alvejamento de il18r1
BR112014005573A2 (pt) Anticorpo monoclonal b7-h6 terapeuticamente ativo contra polipeptídeo b7-h6
EA201290683A1 (ru) Устройство для ослабления симптомов нейродегенеративных заболеваний
BR112013025197A2 (pt) métodos para tratar doença de alzheimer e para avaliar a eficáca de uma terapia destinada a tratar doença de alzheimer
EP4426860A4 (en) DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
AR085164A1 (es) Metodos para el analisis de la placa
PL405046A1 (pl) Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
IN2013CN02996A (es)
MX2024005926A (es) Tratamiento de pacientes con liposarcoma mixoide/de celulas redondas.
UY31535A1 (es) Método para diagnosticar tumores colorrectales
RU2014113841A (ru) Способ ранней диагностики эндогенной интоксикации
BR112019006422A2 (pt) anticorpo monoclonal contra fzd10 e utilização do mesmo
EA201690217A1 (ru) Способ и диагностический набор для контроля рассеянного склероза (pc)
AR076177A1 (es) MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL

Legal Events

Date Code Title Description
FB Suspension of granting procedure